Skip to Main Content

Author Details

Brian R Rood
Brain Tumor Institute, Children's National Hospital
1998
60
28
PMIDPaper TitleJournal TitlePublished Year
36335802The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.Neoplasia2023
36335802The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.Neoplasia2023
37944590Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.Nat Med2023
37160547Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data.Curr Oncol Rep2023
37203791Optical genome mapping identifies a novel pediatric embryonal tumor with a ZNF532::NUTM1 fusion.J Pathol2023
36993741Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.Res Sq2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37944590Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.Nat Med2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37160547Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data.Curr Oncol Rep2023
36993741Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.Res Sq2023
37203791Optical genome mapping identifies a novel pediatric embryonal tumor with a ZNF532::NUTM1 fusion.J Pathol2023
36201019Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.Acta Neuropathol2022
35736214OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma.Clin Cancer Res2022
36201019Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.Acta Neuropathol2022
35736214OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma.Clin Cancer Res2022
34795224Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors.Nat Commun2021
34795224Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors.Nat Commun2021
31562520Germline microsatellite genotypes differentiate children with medulloblastoma.Neuro Oncol2020
32055852Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.Neuro Oncol2020
31562520Germline microsatellite genotypes differentiate children with medulloblastoma.Neuro Oncol2020
33227080<i>HIC1</i> (Hypermethylated in Cancer 1) modulates the contractile activity of prostate stromal fibroblasts and directly regulates <i>CXCL12</i> expression.Oncotarget2020
32562017Correction to: Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.Acta Neuropathol2020
32055852Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.Neuro Oncol2020
33227080<i>HIC1</i> (Hypermethylated in Cancer 1) modulates the contractile activity of prostate stromal fibroblasts and directly regulates <i>CXCL12</i> expression.Oncotarget2020
32562017Correction to: Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.Acta Neuropathol2020
30862721<i>MYC</i> Drives Group 3 Medulloblastoma through Transformation of Sox2<sup>+</sup> Astrocyte Progenitor Cells.Cancer Res2019
30862721<i>MYC</i> Drives Group 3 Medulloblastoma through Transformation of Sox2<sup>+</sup> Astrocyte Progenitor Cells.Cancer Res2019
29880060Proteomic analysis of Medulloblastoma reveals functional biology with translational potential.Acta Neuropathol Commun2018
29880060Proteomic analysis of Medulloblastoma reveals functional biology with translational potential.Acta Neuropathol Commun2018
27935866HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs).Oncotarget2017
28394352Spatial heterogeneity in medulloblastoma.Nat Genet2017
29527139Transactional Pathways of Transgender Identity Development in Transgender and Gender Nonconforming Youth and Caregivers from the Trans Youth Family Study.Int J Transgend2017
27935866HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs).Oncotarget2017
28394352Spatial heterogeneity in medulloblastoma.Nat Genet2017
29527139Transactional Pathways of Transgender Identity Development in Transgender and Gender Nonconforming Youth and Caregivers from the Trans Youth Family Study.Int J Transgend2017
27775567A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.Int J Mol Sci2016
27775567A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.Int J Mol Sci2016
25407389Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study.J Neurooncol2015
25879388Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.Oncotarget2015
25407389Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study.J Neurooncol2015
25970789Proteomic profiling of high risk medulloblastoma reveals functional biology.Oncotarget2015
26540407The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells.Aging (Albany NY)2015
26540407The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells.Aging (Albany NY)2015
25879388Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.Oncotarget2015
25970789Proteomic profiling of high risk medulloblastoma reveals functional biology.Oncotarget2015
24435762Handheld optical coherence tomography during sedation in young children with optic pathway gliomas.JAMA Ophthalmol2014
24297113Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.Acta Neuropathol2014
24435762Handheld optical coherence tomography during sedation in young children with optic pathway gliomas.JAMA Ophthalmol2014
25153720Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas.Oncotarget2014
  • 1 - 50 of 120

Recommended Authors

Kyle S Smith
St. Jude Children's Research Hospital
Career Start Year 2018
Number of shared co-authors 28
David Pauck
German Cancer Research Center (DKFZ)
Career Start Year 2017
Number of shared co-authors 13
Sebastian Brabetz
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2016
Number of shared co-authors 36
Patryk Skowron
University of Toronto
Career Start Year 2015
Number of shared co-authors 42
Giles W Robinson
St. Jude Children's Research Hospital
Career Start Year 2010
Number of shared co-authors 53
Kristian W Pajtler
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Career Start Year 2009
Number of shared co-authors 59
Dominik Sturm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2008
Number of shared co-authors 54
Adrian M Dubuc
Dana-Farber Cancer Institute
Career Start Year 2008
Number of shared co-authors 49
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Career Start Year 2008
Number of shared co-authors 51
Patricia Baxter
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 38
Nicholas G Gottardo
Perth Children's Hospital
Career Start Year 2002
Number of shared co-authors 41
Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 26
Brent A Orr
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 42
Daniel C Bowers
University of Texas Southwestern Medical School
Career Start Year 1998
Number of shared co-authors 46
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 1998
Number of shared co-authors 52
Stefan Rutkowski
University Medical Center Hamburg-Eppendorf
Career Start Year 1997
Number of shared co-authors 63
Rajeev Vibhakar
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Career Start Year 1997
Number of shared co-authors 47
Jaume Mora
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
Career Start Year 1996
Number of shared co-authors 54
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 20
Michael A Grotzer
University Children's Hospital
Career Start Year 1994
Number of shared co-authors 59
Steven C Clifford
Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer
Career Start Year 1994
Number of shared co-authors 51
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 1993
Number of shared co-authors 59
Murali Chintagumpala
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 1990
Number of shared co-authors 38
Guido Reifenberger
Heinrich Heine University
Career Start Year 1987
Number of shared co-authors 42
David W Ellison
St. Jude Children's Research Hospital
Career Start Year 1986
Number of shared co-authors 68
Amar Gajjar
St. Jude Children's Research Hospital
Career Start Year 1986
Number of shared co-authors 65
William A Weiss
University of California san francisco
Career Start Year 1985
Number of shared co-authors 57
James M Olson
Clinical Research Division, Fred Hutchinson Cancer Center
Career Start Year 1985
Number of shared co-authors 53
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 32
Scott L Pomeroy
Harvard Medical School
Career Start Year 1978
Number of shared co-authors 47

Collaborators

Roger J Packer
Brain Tumor Institute, Children's National Hospital
Co-authored papers 24
Dominique Leprince
University Lille, CNRS, INSERM
Co-authored papers 9
Javad Nazarian
USA University of Zurich
Co-authored papers 7
Adam C Resnick
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 5
Eugene I Hwang
Children's National Hospital. Electronic address: .
Co-authored papers 5
Capucine Van Rechem
Stanford University School of Medicine
Co-authored papers 4
John S Myseros
Co-authored papers 4
Gaylor Boulay
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 4
Lindsay Kilburn
Children's National Hospital
Co-authored papers 4
Michael J Fisher
Co-authored papers 4
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 4
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 3
Suresh N Magge
Co-authored papers 3
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 3
Mariarita Santi
Children's Hospital of Philadelphia
Co-authored papers 3
Sana D Karam
University of Colorado School of Medicine
Co-authored papers 3
Amanda M Saratsis
Co-authored papers 3
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers 3
Eric H Raabe
Co-authored papers 3
Sridevi Yadavilli
Co-authored papers 3
Marion Dubuissez
Centre affilie a l'Universite de Montreal
Co-authored papers 3
Sameer Agnihotri
Co-authored papers 3
Madhuri Kambhampati
Co-authored papers 3
Rishi R Lulla
Hasbro Children's Hospital, Brown University.
Co-authored papers 3
Sabine Mueller
University Children's Hospital Zurich
Co-authored papers 3
Heather Gordish-Dressman
Co-authored papers 2
Lauren Boreta
Co-authored papers 2
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers 2
Arie Perry
University of California san francisco
Co-authored papers 2
Stephanie L Pugh
Co-authored papers 2
Release 1.2